Diabetes clinical trial
College of Osteopathic
Medicine looking for
patients newly diagnosed with type 2
Researchers at the Ohio University
Heritage College of Osteopathic Medicine (OU-HCOM)
are recruiting local type 2 diabetes
patients for a clinical trial. The trial
will look at the benefits of short-term
intensive insulin therapy on long-term
Diabetes is a chronic disease of the
pancreas, which secretes insulin to
manage blood sugar, also called glucose.
In type 2 diabetes, the most common form
of diabetes, the pancreas eventually
loses its ability to secrete insulin in
response to meals.
“Recent studies have shown that
intensive insulin treatment at the onset
of type 2 diabetes can prevent
pancreatic failure early in the disease,
leading to long-term control of glucose
and reducing the need for costly
treatment measures down the road,” said
Jay Shubrook, D.O., the primary
investigator on the trial.
In a previous case series (recently
accepted in the journal Insulin),
Shubrook administered 12 weeks of
intensive insulin therapy to newly
diagnosed diabetes patients. Since then,
the patients have benefited from stable
glucose levels for up to two and a half
years – with no medication. Normally,
Shubrook said, a type 2 diabetes patient
starts with one medication to control
glucose levels and has to increase his
or her medications over time to keep
glucose in control.
In Appalachian Ohio, more than 11
percent of the population has diabetes,
compared to the national rate of eight
percent, as reported by the Ohio
Department of Health. The department
estimates that an additional 30,000
Appalachian Ohio residents may have
diabetes but are not diagnosed.
The physician researchers at OU-HCOM are
looking for adults who have been
diagnosed with type 2 diabetes within
the past six months and who do not have
congestive heart failure, renal failure,
or nephrotic syndrome.
Trial participants will receive free
medical visits and laboratory testing,
medication and testing supplies for one
year, in addition to payments for each
visit they attend and the opportunity to
gain control of their diabetes.
To sign up or to receive more
information, call 1-877-762-3888.
For media interviews with Dr. Shubrook,
contact Richard Heck at 740-593-0896.